Wolverine Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.17M | Buy |
16,900
+13,300
| +369% | +$4.47M | 0.01% | 1148 |
|
|
2025
Q2 | $1.02M | Buy |
+3,600
| New | +$1.08M | ﹤0.01% | 2284 |
|
|
2025
Q1 | – | Sell |
-1,500
| Closed | -$536K | – | 5902 |
|
|
2024
Q4 | $536K | Buy |
+1,500
| New | +$551K | ﹤0.01% | 3323 |
|
|
2024
Q2 | – | Sell |
-4,100
| Closed | -$942K | – | 5261 |
|
|
2024
Q1 | $942K | Buy |
+4,100
| New | +$925K | ﹤0.01% | 2255 |
|
|
2023
Q4 | – | Sell |
-1,900
| Closed | -$429K | – | 5269 |
|
|
2023
Q3 | $429K | Buy |
1,900
+100
| +6% | +$23K | ﹤0.01% | 2913 |
|
|
2023
Q2 | $396K | Buy |
+1,800
| New | +$399K | ﹤0.01% | 2824 |
|
|
2022
Q4 | – | Sell |
-1,100
| Closed | -$229K | – | 5097 |
|
|
2022
Q3 | $229K | Buy |
+1,100
| New | +$246K | ﹤0.01% | 3445 |
|
|
2022
Q1 | – | Sell |
-2,400
| Closed | -$516K | – | 6506 |
|
|
2021
Q4 | $516K | Sell |
2,400
-500
| -17% | -$98.2K | ﹤0.01% | 3417 |
|
|
2021
Q3 | $538K | Sell |
2,900
-10,900
| -79% | -$2.15M | ﹤0.01% | 3832 |
|
|
2021
Q2 | $2.44M | Buy |
13,800
+8,100
| +142% | +$1.54M | ﹤0.01% | 1780 |
|
|
2021
Q1 | $943K | Sell |
5,700
-4,400
| -44% | -$734K | ﹤0.01% | 2835 |
|
|
2020
Q4 | $1.5M | Sell |
10,100
-2,000
| -17% | -$262K | ﹤0.01% | 1969 |
|
|
2020
Q3 | $1.22M | Buy |
12,100
+5,000
| +70% | +$549K | ﹤0.01% | 1879 |
|
|
2020
Q2 | $852K | Sell |
7,100
-9,800
| -58% | -$1.1M | ﹤0.01% | 2179 |
|
|
2020
Q1 | $1.64M | Buy |
+16,900
| New | +$1.61M | 0.01% | 1511 |
|
|
2019
Q4 | – | Sell |
-22,700
| Closed | -$1.83M | – | 5248 |
|
|
2019
Q3 | $1.83M | Sell |
22,700
-200
| -0.9% | -$16.1K | 0.01% | 1496 |
|
|
2019
Q2 | $1.79M | Sell |
22,900
-1,800
| -7% | -$168K | 0.01% | 1592 |
|
|
2019
Q1 | $2.9M | Buy |
+24,700
| New | +$2.88M | 0.01% | 1235 |
|
|
2018
Q4 | – | Sell |
-9,600
| Closed | -$1.23M | – | 5391 |
|
|
2018
Q3 | $1.23M | Sell |
9,600
-6,200
| -39% | -$767K | ﹤0.01% | 2126 |
|
|
2018
Q2 | $1.77M | Hold |
15,800
| – | – | ﹤0.01% | 1689 |
|
|
2018
Q1 | $1.77M | Sell |
15,800
-8,500
| -35% | -$1.08M | ﹤0.01% | 1689 |
|
|
2017
Q4 | $3.6M | Buy |
24,300
+2,400
| +11% | +$305K | 0.01% | 1082 |
|
|
2017
Q3 | $2.57M | Sell |
21,900
-28,600
| -57% | -$3.65M | 0.01% | 1175 |
|
|
2017
Q2 | $6.63M | Buy |
50,500
+38,500
| +321% | +$4.8M | 0.03% | 540 |
|
|
2017
Q1 | $1.64M | Sell |
12,000
-500
| -4% | -$75.7K | 0.01% | 1334 |
|
|
2016
Q4 | $1.79M | Buy |
12,500
+3,300
| +36% | +$421K | 0.01% | 1423 |
|
|
2016
Q3 | $1.06M | Sell |
9,200
-3,400
| -27% | -$409K | ﹤0.01% | 1803 |
|
|
2016
Q2 | $1.3M | Buy |
+12,600
| New | +$1.41M | 0.01% | 1393 |
|
Other funds holding UTHR
ACA
DGM
Wolverine Trading's UTHR Position: Q3 2025 in Review
Wolverine Trading sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,307 shares — an estimated $440K sold.
Wolverine Trading first reported a position in UTHR in Q4 2016 and held it in 14 quarters. The position peaked at $2.65M in Q4 2017. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.
- Wolverine Trading reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 1,307 United Therapeutics shares in Q3 2025, an estimated $440K.
- Wolverine Trading first reported a position in United Therapeutics in Q4 2016 and held it in 14 quarters.
- Wolverine Trading's United Therapeutics position peaked at $2.65M in Q4 2017.
- 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.